Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome
Aswathi Kumar
, Laura Hollar
,
Janet B. McGill
,
Premal H. Thaker
,
Maamoun Salam
Division of Endocrinology, Metabolism & Lipid Research
Institute of Clinical and Translational Sciences (ICTS)
Division of Gynecologic Oncology
Siteman Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Serous Ovarian Carcinoma
100%
17q12 Deletion Syndrome
100%
Maturity-onset Diabetes of the Young type 5
100%
Ovarian Cancer
42%
Diabetes
28%
HNF1A
28%
Gene mutation
14%
Ovarian Tumor
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Psychiatric Disorders
14%
Cervix
14%
Ascites
14%
Disease Association
14%
Older Women
14%
Genetic Testing
14%
Patients with Diabetes
14%
Medical Providers
14%
Salpingo-oophorectomy
14%
Susceptibility Loci
14%
Chromosomal Microarray
14%
Stage IIIC
14%
Total Abdominal Hysterectomy
14%
Endocrinology
14%
Laparoscopy
14%
C-peptide Levels
14%
Neurodevelopmental Disorders
14%
Lymph Node Dissection
14%
Low-grade Serous Ovarian Carcinoma
14%
Urogenital Tract
14%
Omental
14%
Abdominal Computed Tomography
14%
Solitary Kidney
14%
Hg19
14%
Recently Diagnosed
14%
Pancreatic Atrophy
14%
Septate Uterus
14%
Omentectomy
14%
Urogenital Anomalies
14%
Ovarian Clear Cell Carcinoma
14%
Nodularity
14%
Vaginal Septum
14%
Bicornuate Uterus
14%
Uterine Abnormalities
14%
Non-clear Cell Carcinoma
14%
Urogenital Abnormalities
14%
Gut Abnormalities
14%
Low-grade Serous Ovarian Cancer
14%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Krukenberg Tumor
100%
Diabetes
42%
Ovarian Cancer
42%
Hepatocyte Nuclear Factor 1
28%
Urogenital Tract Malformation
28%
Cancer
14%
Carcinoma
14%
Disease Predisposition
14%
Gene Mutation
14%
Gut
14%
Computer Assisted Tomography
14%
Disease
14%
Cervix
14%
Disease Association
14%
Laparoscopic Surgery
14%
Retroperitoneal Lymph Node Dissection
14%
Genetic Screening
14%
Ovarian Tumor
14%
C-Peptide
14%
Salpingooophorectomy
14%
Ascites
14%
Clear Cell Carcinoma
14%
Abdominal Hysterectomy
14%
Endocrinology
14%
Array Comparative Genomic Hybridization
14%
Type 1 Diabetes
14%
Solitary Kidney
14%
Omentectomy
14%
Bicornuate Uterus
14%